Findings from Myriad Genetics Inc. Yields New Data on Familial Cancer (Interpretation of Brca2 Splicing Variants: a Case Series of Challenging Variant Interpretations and the Importance of Functional Rna Analysis)

MLA

“Findings from Myriad Genetics Inc. Yields New Data on Familial Cancer (Interpretation of Brca2 Splicing Variants: A Case Series of Challenging Variant Interpretations and the Importance of Functional Rna Analysis).” Health & Medicine Week, 26 Feb. 2021, p. 2524. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.652554176&authtype=sso&custid=ns315887.

APA

Findings from Myriad Genetics Inc. Yields New Data on Familial Cancer (Interpretation of Brca2 Splicing Variants: a Case Series of Challenging Variant Interpretations and the Importance of Functional Rna Analysis). (2021, February 26). Health & Medicine Week, 2524.

Chicago

Health & Medicine Week. 2021. “Findings from Myriad Genetics Inc. Yields New Data on Familial Cancer (Interpretation of Brca2 Splicing Variants: A Case Series of Challenging Variant Interpretations and the Importance of Functional Rna Analysis),” February 26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.652554176&authtype=sso&custid=ns315887.